BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6917646)

  • 1. Mevinolin: a highly specific inhibitor of microsomal 3-hydroxy-3-methylglutaryl-coenzyme A reductase of radish plants.
    Bach TJ; Lichtenthaler HK
    Z Naturforsch C Biosci; 1982; 37(1-2):46-50. PubMed ID: 6917646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of inhibition by mevinolin (MK 803) of microsome-bound radish and of partially purified yeast HMG-CoA reductase (EC.1.1.1.34).
    Bach TJ; Lichtenthaler HK
    Z Naturforsch C Biosci; 1983; 38(3-4):212-9. PubMed ID: 6553442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.
    Alberts AW; Chen J; Kuron G; Hunt V; Huff J; Hoffman C; Rothrock J; Lopez M; Joshua H; Harris E; Patchett A; Monaghan R; Currie S; Stapley E; Albers-Schonberg G; Hensens O; Hirshfield J; Hoogsteen K; Liesch J; Springer J
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):3957-61. PubMed ID: 6933445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of cholestyramine and Mevinolin on the diurnal cycle of rat hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase.
    Tanaka RD; Edwards PA; Lan SF; Knöppel EM; Fogelman AM
    J Lipid Res; 1982 Sep; 23(7):1026-31. PubMed ID: 6923909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monacolin K, a new hypocholesterolemic agent that specifically inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase.
    Endo A
    J Antibiot (Tokyo); 1980 Mar; 33(3):334-6. PubMed ID: 7380744
    [No Abstract]   [Full Text] [Related]  

  • 6. Rapid and substantial lowering of human serum cholesterol by mevinolin (MK-803), an inhibitor of hydroxymethylglutaryl-coenzyme A reductase.
    Tobert JA; Hitzenberger G; Kukovetz WR; Holmes IB; Jones KH
    Atherosclerosis; 1982 Jan; 41(1):61-5. PubMed ID: 6918220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxymethylglutaryl-coenzyme A reductase-containing hepatocytes are distributed periportally in normal and mevinolin-treated rat livers.
    Singer II; Kawka DW; Kazazis DM; Alberts AW; Chen JS; Huff JW; Ness GC
    Proc Natl Acad Sci U S A; 1984 Sep; 81(17):5556-60. PubMed ID: 6382266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of murine neuroblastoma growth in vivo by mevinolin, a competitive inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
    Maltese WA; Defendini R; Green RA; Sheridan KM; Donley DK
    J Clin Invest; 1985 Nov; 76(5):1748-54. PubMed ID: 3850904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of degradation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by mevinolin.
    Sinensky M; Logel J
    J Biol Chem; 1983 Jul; 258(14):8547-9. PubMed ID: 6553055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 4. Side chain ester derivatives of mevinolin.
    Hoffman WF; Alberts AW; Anderson PS; Chen JS; Smith RL; Willard AK
    J Med Chem; 1986 May; 29(5):849-52. PubMed ID: 3634830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A somatic cell mutant with a kinetically altered 3-hydroxy-3-methylglutaryl coenzyme A reductase.
    Sinensky M; Logel J; Schnitzer-Polokoff R; Norcross RA
    FEBS Lett; 1985 Jul; 186(2):219-23. PubMed ID: 3847351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative lipophilicities, solubilities, and structure-pharmacological considerations of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors pravastatin, lovastatin, mevastatin, and simvastatin.
    Serajuddin AT; Ranadive SA; Mahoney EM
    J Pharm Sci; 1991 Sep; 80(9):830-4. PubMed ID: 1800703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of substrates and competitive inhibitors on the phosphatase-dependent activation of hepatic hydroxymethylglutaryl CoA reductase.
    Feingold KR; Moser AH
    Arch Biochem Biophys; 1986 Aug; 249(1):46-52. PubMed ID: 3017222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monacolin M, a new inhibitor of cholesterol biosynthesis.
    Endo A; Komagata D; Shimada H
    J Antibiot (Tokyo); 1986 Dec; 39(12):1670-3. PubMed ID: 3818440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of mevinolin in rat liver: evidence for a lack of coupling between synthesis of hydroxymethylglutaryl-CoA reductase and cholesterol 7 alpha-hydroxylase activity.
    Björkhem I
    Biochim Biophys Acta; 1986 Jun; 877(1):43-9. PubMed ID: 3636157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of rat brain prostaglandin D synthase by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
    Islam F; Watanabe Y; Hayaishi O
    Biochem Int; 1990 Nov; 22(4):601-5. PubMed ID: 2127671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydromevinolin, a potent hypocholesterolemic metabolite produced by Aspergillus terreus.
    Albers-Schönberg G; Joshua H; Lopez MB; Hensens OD; Springer JP; Chen J; Ostrove S; Hoffman CH; Alberts AW; Patchett AA
    J Antibiot (Tokyo); 1981 May; 34(5):507-12. PubMed ID: 7275832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mode of interaction of beta-hydroxy-beta-methylglutaryl coenzyme A reductase with strong binding inhibitors: compactin and related compounds.
    Nakamura CE; Abeles RH
    Biochemistry; 1985 Mar; 24(6):1364-76. PubMed ID: 3886005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors.
    Endo A
    Methods Enzymol; 1981; 72():684-9. PubMed ID: 7311861
    [No Abstract]   [Full Text] [Related]  

  • 20. Regulation of plasma cholesterol by compactin and mevinolin.
    Nutr Rev; 1985 Sep; 43(9):266-8. PubMed ID: 3903562
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.